KyooBe Tech is a specialized technology developer focusing on the commercialization of innovative pharmaceutical production technologies. Founded in 2020 as a corporate start-up of the Bausch+Ströbel group, KyooBe Tech has grown to a team of 21 motivated engineers and biotechnologists. The main application areas of our technologies are pathogen inactivation and cell and gene therapy manufacturing.

INACTIVATE, our first product line entering the market in 2024, aims to inactivate pathogens with low-energy electron irradiation. The main applications are in vaccine production and for processes ranging from selective degradation to the complete inactivation of infectious pathogens. Other potential applications include virus depletion in process media and even cell therapeutics. Since 2022, KyooBe Tech has successfully been operating a test platform to optimize the process parameters for individual product irradiation applications.

MOSAIC is a modular manufacturing platform for personalized medicine. It´s a cube-based “matrix high rack” production system, each constructed as independent units. The vision is, to offer individual cell and gene therapy on an industrial scale.